10.03.2010 • NewsHexionBilanzsales and profits

Hexion Q4 Net Loss Narrows; Sales Drop

Privately held Hexion Specialty Chemicals said its fourth-quarter net loss narrowed sharply, helped in part by falling costs and improving volume.

For the period, the company posted a net loss of $6 million compared with $921 million in the year-ago period.

The year-ago period includes a one-time charge of $800 million the company paid to Huntsman as part of a settlement to cancel its plans to acquire that company.

Hexion said its asset impairment costs and business realignment costs fell during the period.

Revenue decreased 7.6% to $1.09 billion.

The company said raw material prices were lower and that volume jumped 5%. Volume is the physical amount of product sold.

Hexion is owned by Apollo Management, a private equity firm that also owns the Harrah's casino chain and Norwegian Cruise Lines.

The company said earlier this year it wanted to extend some of its term loans until May 2015 and issue $700 million in senior notes.

Company

Hexion Specialty Chemicals

Gennaerstr. 2-4
58642 Iserlohn
Germany

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.